CellPath

Executive Summary

CellPath is a UK-based manufacturer and supplier of products, consumables, and services for the histopathology and cytology markets. Founded in 1970, the company offers a comprehensive portfolio that supports laboratory workflows from specimen transport to archiving. As part of the StatLab group and ISO 13485 certified, CellPath emphasizes quality and reliability in diagnostic laboratory supplies. The company serves a global customer base, leveraging its long-standing expertise and reputation in the pathology community. CellPath operates in the mature but steady diagnostic supplies sector, with growth driven by increasing demand for cancer diagnostics and laboratory automation. While the company is privately held and lacks public financial disclosures, it benefits from being part of a larger group with resources for expansion. Key risks include competition from larger diagnostics companies and potential supply chain disruptions. Overall, CellPath represents a stable but low-growth opportunity in the diagnostics value chain.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Histopathology Consumables70% success
• Q4 2026Expansion into Emerging Markets (e.g., Asia-Pacific)60% success
• TBDStrategic Partnership or Acquisition by Parent Company StatLab50% success